drugset / Trial / NCT01536210

Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)

NCT01536210

Phase 3 Completed 144 enrolled Yuyu Pharma, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate clinical efficacy and safety of treatment with YY-162 in children with ADHD.

Timeline

Start
2011-12
Primary completion
2012-08
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 30 mg Oral
Subject Ginseng extract Unknown 50 mg Oral

Indications